APOC3 and coronary artery disorder: In addition, individuals with loss-of-function APOC3 showed 40% lower plasma TG levels, 40% lower risk for CHD, and 60% lower risk for ischemic vascular disease compared to non-carriers, implying a causal relationship between apoC-III and CVD (85, 86).